Cargando…

Predictors of Pulmonary Function Response to Treatment with Salmeterol/fluticasone in Patients with Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and responses to therapies are highly variable. The aim of this study was to identify the predictors of pulmonary function response to 3 months of treatment with salmeterol/fluticasone in patients with COPD. A total of 127 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jae Seung, Huh, Jin Won, Chae, Eun Jin, Seo, Joon Beom, Ra, Seung Won, Lee, Ji-Hyun, Kim, Eun-Kyung, Lee, Young Kyung, Kim, Tae-Hyung, Kim, Woo Jin, Lee, Jin Hwa, Lee, Sang-Min, Lee, Sangyeub, Lim, Seong Yong, Shin, Tae Rim, Yoon, Ho Il, Sheen, Seung Soo, Oh, Yeon-Mok, Lee, Sang-Do
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051085/ https://www.ncbi.nlm.nih.gov/pubmed/21394306 http://dx.doi.org/10.3346/jkms.2011.26.3.379

Ejemplares similares

Pharmacokinetic characteristics of fluticasone, salmeterol and tiotropium after concurrent inhalation
por: Sunwoo, Jung, et al.
Publicado: (2017)

Comparison of Clinico-Physiologic and CT Imaging Risk Factors for COPD Exacerbation
por: Yoo, Jung-Wan, et al.
Publicado: (2011)

Prognostic value of blood biomarkers in patients with unprovoked acute pulmonary embolism
por: Lee, Joo Hee, et al.
Publicado: (2019)

Pulmonary complications after abdominal surgery in patients with mild-to-moderate chronic obstructive pulmonary disease
por: Kim, Tae Hoon, et al.
Publicado: (2016)

Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Dexamethasone/salmeterol/fluticasone-propionate: Invasive pulmonary Aspergillosis: case report
Publicado: (2021)

Three-month Treatment Response and Exacerbation in Chronic Obstructive Pulmonary Disease
por: Lee, Jung Su, et al.
Publicado: (2015)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic Obstructive Pulmonary Disease
por: Koser, Andras, et al.
Publicado: (2010)

Salmeterol/fluticasone combination in the treatment of COPD
por: Chung, K F
Publicado: (2006)

Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Hwang, Jae-Joon, et al.
Publicado: (2020)

Analysis of high predicted pulmonary function: possibility of overestimation in small elderly examinees
por: Chang, Youjin, et al.
Publicado: (2020)

Visual and Quantitative Assessments of Regional Xenon-Ventilation Using Dual-Energy CT in Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Comparison with Chronic Obstructive Pulmonary Disease
por: Hwang, Hye Jeon, et al.
Publicado: (2020)

Central Extracorporeal Membrane Oxygenation and Early Rehabilitation for Persistent Severe Pulmonary Hypertension Following Pulmonary Endarterectomy
por: Seong, Gil Myeong, et al.
Publicado: (2019)

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
por: Halpern, Rachel, et al.
Publicado: (2011)

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
por: Yasui, Hideki, et al.
Publicado: (2018)

Prediction of Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Correlation with Quantitative CT Parameters
por: Koo, Hyun Jung, et al.
Publicado: (2019)

Utility of Computed Tomography in a Differential Diagnosis for the Patients with an Initial Diagnosis of Chronic Obstructive Pulmonary Disease Exacerbation
por: Park, Hyung Jun, et al.
Publicado: (2019)

Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease
por: Kim, Joohae, et al.
Publicado: (2015)

Clinical Usefulness of Sonoelastography in Infants With Congenital Muscular Torticollis
por: Hong, Seong Kyung, et al.
Publicado: (2016)

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
por: Jin, Xiaofen, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease Is Associated With Decreased Quality of Life in Bronchiectasis Patients: Findings From the KMBARC Registry
por: Kim, Sang Hyuk, et al.
Publicado: (2021)

Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
por: Yu, Iseul, et al.
Publicado: (2022)

Quantitative Vertebral Bone Density Seen on Chest CT in Chronic Obstructive Pulmonary Disease Patients: Association with Mortality in the Korean Obstructive Lung Disease Cohort
por: Hwang, Hye Jeon, et al.
Publicado: (2020)

Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
por: Mills, Hilla, et al.
Publicado: (2022)

Whole lung lavage using a rapid infusion system to treat a patient with pulmonary alveolar proteinosis
por: Ra, Seung Won, et al.
Publicado: (2019)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
por: Park, Yong Bum, et al.
Publicado: (2023)

Efficacy of Unsupervised Home-Based Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease
por: Lee, Jang Ho, et al.
Publicado: (2020)

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
por: Ohar, Jill A, et al.
Publicado: (2014)

The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease
por: Shin, Tae Rim, et al.
Publicado: (2015)

Concurrent Diagnosis of Pulmonary Metastasis of Malignant Mixed Müllerian Tumor and Small Cell Lung Cancer
por: Lee, Young Jin, et al.
Publicado: (2012)

NLRX1 knockdown attenuates pro-apoptotic signaling and cell death in pulmonary hyperoxic acute injury
por: Kim, Hye Rin, et al.
Publicado: (2023)

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi, Jae-Hwa, et al.
Publicado: (2021)

The Relationship Between Comorbidities and Microbiologic Findings in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Seo, Hyewon, et al.
Publicado: (2022)

Determinants of Nicotine Dependence in Chronic Obstructive Pulmonary Disease
por: Sim, Yun Su, et al.
Publicado: (2017)

A Case Report of Breast Cancer with Extensive Pulmonary Lymphovascular Tumor Emboli
por: Yang, Yaewon, et al.
Publicado: (2012)

Total Occlusion of Right Main Pulmonary Artery in a Patient with Takayasu's Arteritis and Severe Pulmonary Hypertension
por: Choi, Hong-Mi, et al.
Publicado: (2012)

New Method for Combined Quantitative Assessment of Air-Trapping and Emphysema on Chest Computed Tomography in Chronic Obstructive Pulmonary Disease: Comparison with Parametric Response Mapping
por: Hwang, Hye Jeon, et al.
Publicado: (2021)

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?
por: Akamatsu, Keiichiro, et al.
Publicado: (2011)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
por: Moon, Sung Woo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9agndf50dcanaj2slbgrkh7962